Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113

被引：0

作者：

Tatsuya Okuno ^{[1
]}

Chigusa Morizane ^{[2
]}

Junki Mizusawa ^{[3
]}

Hiroaki Yanagimoto ^{[4
]}

Satoshi Kobayashi ^{[5
]}

Hiroshi Imaoka ^{[6
]}

Takeshi Terashima ^{[7
]}

Hisato Kawakami ^{[1
]}

Yusuke Sano ^{[3
]}

Takuji Okusaka ^{[2
]}

Masafumi Ikeda ^{[6
]}

Masato Ozaka ^{[8
]}

Haruo Miwa ^{[9
]}

Akiko Todaka ^{[10
]}

Satoshi Shimizu ^{[11
]}

Nobumasa Mizuno ^{[12
]}

Mitsugu Sekimoto ^{[13
]}

Keiji Sano ^{[14
]}

Kazutoshi Tobimatsu ^{[15
]}

Akio Katanuma ^{[16
]}

Kunihito Gotoh ^{[17
]}

Hironori Yamaguchi ^{[18
]}

Hiroshi Ishii ^{[19
]}

Junji Furuse ^{[5
]}

Makoto Ueno ^{[5
]}

机构：

[1] Kindai University,Department of Medical Oncology, Faculty of Medicine

[2] Osakasayama City,Department of Hepatobiliary and Pancreatic Oncology

[3] National Cancer Center Hospital,JCOG Data Center/Operations Office

[4] National Cancer Center Hospital,Department of Surgery, Division of Hepato

[5] Kobe University Graduate School of Medicine,Biliary

[6] Kanagawa Cancer Center,Pancreatic Surgery

[7] National Cancer Center Hospital East,Department of Gastroenterology

[8] Kanazawa University Hospital,Department of Hepatobiliary and Pancreatic Oncology

[9] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology

[10] Yokohama City University Medical Center,Hepato

[11] Shizuoka Cancer Center,Biliary

[12] Saitama Cancer Center,Pancreatic Medicine Department

[13] Aichi Cancer Center Hospital,Gastroenterological Center

[14] Kansai Medical University Hospital,Division of Gastrointestinal Oncology

[15] Teikyo University School of Medicine,Department of Gastroenterology

[16] Kobe University Graduate School of Medicine,Department of Gastroenterology

[17] Teine Keijinkai Hospital,Department of Surgery

[18] NHO Osaka National Hospital,Department of Surgery

[19] Jichi Medical University,Division of Gastroenterology, Department of Internal Medicine

[20] Chiba Cancer Center,Center for Gastroenterology

来源：

International Journal of Clinical Oncology | 2025年 / 30卷 / 1期

关键词：

Biliary tract cancers; Chemotherapy; Major hepatectomy;

D O I：

10.1007/s10147-024-02642-9

中图分类号：

学科分类号：

摘要：

引用

页码：83 / 91

页数：8

共 50 条

[31] Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer
Nakamura, Ikuo
Hatano, Etsuro
Baba, Hideo
Kamei, Keiko
Wada, Hiroshi
Shimizu, Junzo
Kanai, Masahumi
Yoshimura, Kenichi
Nagano, Hiroaki
Ioka, Tatsuya
ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (06): : 1009 - 1020
[32] Analysis of early tumor shrinkage and depth of response in patients with advanced biliary tract cancer treated with gemcitabine plus cisplatin or gemcitabine plus S-1: An exploratory analysis of JCOG1113.
Okano, Naohiro
Morizane, Chigusa
Okusaka, Takuji
Sadachi, Ryo
Kataoka, Tomoko
Ueno, Makoto
Ikeda, Masafumi
Ozaka, Masato
Sugimori, Kazuya
Todaka, Akiko
Shimizu, Satoshi
Mizuno, Nobumasa
Yamamoto, Tomohisa
Sano, Keiji
Tobimatsu, Kazutoshi
Katanuma, Akio
Miyamoto, Atsushi
Yamaguchi, Hironori
Ishii, Hiroshi
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[33] Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).
Ueno, Makoto
Morizane, Chigusa
Okusaka, Takuji
Mizusawa, Junki
Katayama, Hiroshi
Ikeda, Masafumi
Ozaka, Masato
Sugimori, Kazuya
Fukutomi, Akira
Hara, Hiroki
Mizuno, Nobumasa
Yanagimoto, Hiroaki
Sano, Keiji
Tobimatsu, Kazutoshi
Yane, Kei
Nakamori, Shoji
Sata, Naohiro
Yukisawa, Seigo
Ishii, Hiroshi
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[34] Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).
Morizane, Chigusa
Okusaka, Takuji
Mizusawa, Junki
Katayama, Hiroshi
Ueno, Makoto
Ikeda, Masafumi
Ozaka, Masato
Sugimori, Kazuya
Fukutomi, Akira
Hara, Hiroki
Mizuno, Nobumasa
Yanagimoto, Hiroaki
Sano, Keiji
Tobimatsu, Kazutoshi
Yane, Kei
Nakamori, Shoji
Sata, Naohiro
Yukisawa, Seigo
Ishii, Hiroshi
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
[35] Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer
de Jesus, Victor H. F.
Camandaroba, Marcos P. G.
Calsavara, Vinicius F.
Riechelmann, Rachel P.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[36] Colonization of bile with gammaproteobacteria reduces survival after surgery for pancreatic cancer in patients receiving gemcitabine-based adjuvant chemotherapy
Terry, Charlotte
Halle-Smith, James
Sutcliffe, Robert
Marudanayagam, Ravi
Chatzizacharias, Nikolaos
Dasari, Bobby
Bartlett, David
Raza, Syed
Roberts, Keith
BRITISH JOURNAL OF SURGERY, 2024, 111
[37] Original Research Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies
Edeline, Julien
Hirano, Satoshi
Bertaut, Aurelie
Konishi, Masaru
Benabdelghani, Meher
Uesaka, Katsuhiko
Watelet, Jerome
Ohtsuka, Masayuki
Hammel, Pascal
Kaneoka, Yuji
Joly, Jean-Paul
Yamamoto, Masakazu
Monard, Laure
Ambo, Yoshiyasu
Louvet, Christophe
Ando, Masahiko
Malka, David
Nagino, Masato
Phelip, Jean-Marc
Ebata, Tomoki
EUROPEAN JOURNAL OF CANCER, 2022, 164 : 80 - 87
[38] A randomized phase II trial of adjuvant chemotherapy with gemcitabine versus S-1 after major hepatectomy for biliary tract cancer: Kansai Hepato-Biliary Oncology Group (KHBO1208)
Terajima, H.
Kobayashi, S.
Nagano, H.
Tomokuni, A.
Gotoh, K.
Sakai, D.
Hatano, E.
Seo, S.
Uchida, Y.
Ajiki, T.
Satake, H.
Kamei, K.
Tohyama, T.
Hirose, T.
Ikai, I.
Morita, S.
Ioka, T.
ANNALS OF ONCOLOGY, 2018, 29
[39] Combination of 5-FU-based chemotherapy and radiation therapy after surgery for biliary tract cancer
Kurtz, JE
Jung, GM
Jaeck, D
Rohr, S
Bachelier, P
Meyer, C
Dufour, P
ANNALS OF ONCOLOGY, 1998, 9 : 52 - 52
[40] Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
Toyoda, Masanori
Ajiki, Tetsuo
Fujiwara, Yutaka
Nagano, Hiroaki
Kobayashi, Shogo
Sakai, Daisuke
Hatano, Etsuro
Kanai, Masashi
Nakamori, Shoji
Miyamoto, Atsushi
Tsuji, Akihito
Kaihara, Satoshi
Ikoma, Hisashi
Takemura, Shigekazu
Toyokawa, Hideyoshi
Terajima, Hiroaki
Morita, Satoshi
Ioka, Tatsuya
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1295 - 1301

← 1 2 3 4 5 →